IMMUNTHERAPIE MIT DENDRITISCHEN ZELLEN
European patent · EP3291821 · In force
Register entry
- Publication number
- EP3291821
- Application number
- EP16790145
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- May 6, 2016
- Published
- Mar 14, 2018
- Granted
- Feb 25, 2026
- Protection ends at the latest
- May 5, 2036
- Next annual fee due
- May 31, 2027
- IPC classes
- A61K 35/15 (2025.01)A61K 39/39 (2006.01)A61K 38/17 (2006.01)A61K 38/21 (2006.01)A61K 31/4745 (2006.01)A61K 31/708 (2006.01)A61K 31/713 (2006.01)A61K 40/10 (2025.01)A61K 40/19 (2025.01)A61K 40/24 (2025.01)A61K 40/42 (2025.01)A61K 45/06 (2006.01)C12N 5/0784 (2010.01)A61K 39/00 (2006.01)A61P 35/00 (2006.01)A61P 37/04 (2006.01)
- Priority
- US 201562158237 P 07.05.2015
- PCT application
- PCT/US2016/031157 06.05.2016
- PCT publication
- WO2016/179475 10.11.2016
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 1, 2026
Change
Published in Swissreg on 01.06.2026
- May 18, 2026
Agent entered
- Representative
- Vossius & Partner Patentanwälte Rechtsanwälte mbB, Hirschgässlein 11, 4051 Basel
Published in Swissreg on 18.05.2026
- Feb 25, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 25.02.2026
Parties
Inventor
DECKER, William, K.
Houston, TX 77030, US
HALPERT, Matthew
Houston, TX 77030, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.